Internal Medicine, Hematology & Oncology · Renton, WA
NPI
1366553513
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3915 Talbot Rd S, Suite 300
Renton, WA, 98055
Phone (425) 690-3409
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
1,833 services
Medicare patients, 2024
297
Average age 75
Drug cost, 2024
$5.2M
2,395 prescriptions
Company payments, 2025
$818
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle M Zhang was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 733 times for 245 patients. In total Michelle M Zhang billed 1,833 services in 18 codes, and Medicare paid $143K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 733 | 245 | $13.62 | $9,983 |
| 99215 Office E&M - Established | Office | 571 | 142 | $144.90 | $83K |
| 99214 Office E&M - Established | Office | 320 | 200 | $96.18 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 59 | 26 | $97.03 | $5,725 |
| 99223 Hospital E&M - Initial | Facility | 32 | 32 | $140.02 | $4,481 |
| 99205 Office E&M - New | Office | 21 | 21 | $172.63 | $3,625 |
| G0008 Administration of influenza virus vaccine | Office | 20 | 20 | $35.62 | $712 |
| 90662 Vaccine Product | Office | 19 | 19 | $41.16 | $782 |
By year: 2022 $189K for 1,728 services; 2023 $164K for 1,395 services; 2024 $143K for 1,833 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle M Zhang prescribed most often to Medicare patients was Anastrozole, with 400 prescriptions and refills. In total Michelle M Zhang wrote 2,395 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 400 | 882 | 91 | $4,477 |
| Hydroxyurea Generic | 110 | 205 | 22 | $2,769 |
| Ondansetron Hcl Generic | 106 | 110 | 52 | $1,057 |
| Prochlorperazine Maleate Generic | 97 | 97 | 51 | $2,010 |
| Potassium Chloride Generic | 95 | 121 | 22 | $980 |
| Gabapentin Generic | 78 | 98 | 17 | $1,051 |
| Prednisone Generic | 75 | 105 | 19 | $303 |
| Abiraterone Acetate Generic | 74 | 74 | Under 11 | $193K |
| Eliquis Apixaban | 66 | 100 | 17 | $59K |
| Acyclovir Generic | 63 | 71 | 11 | $649 |
| Imbruvica Ibrutinib | 57 | 57 | Under 11 | $832K |
| Dexamethasone Generic | 52 | 63 | 26 | $1,123 |
| Xtandi Enzalutamide | 50 | 50 | Under 11 | $737K |
| Letrozole Generic | 49 | 106 | 11 | $1,314 |
| Exemestane Generic | 48 | 76 | Under 11 | $5,733 |
Brand drugs: 425 claims; generic drugs: 1,970 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle M Zhang $818 ($818 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $188.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $188 |
| Genentech, Inc. ROG.SW | 1 | $132 |
| Lilly USA, LLC LLY | 1 | $107 |
| Stemline Therapeutics Inc. | 1 | $93.48 |
| Janssen Biotech, Inc. JNJ | 2 | $78.71 |
| Pfizer Inc. PFE | 2 | $63.53 |
| GlaxoSmithKline, LLC. GSK | 2 | $58.57 |
| Celgene Corporation BMY | 1 | $42.63 |
| Hologic Sales and Service, LLC HOLX | 1 | $30.81 |
| Tempus AI, Inc TEM | 1 | $23.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.